Angus, United Kingdom

Peter Martin Fischer

This inventor holds 20 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents, primarily in Cancer Therapeutics. Top assignees: Cyclacel Limited, Cancer Research Technology Limited, Cyclacel Limted. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Martin Fischer. Retrieved from https://idiyas.com/inventor/peter-martin-fischer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 25.0

 


Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 161(Granted Patents)


Location History:

  • Angus, GB (2002 - 2009)
  • Arbroath, GB (2008 - 2009)
  • Nottingham, GB (2011)
  • Beeston, GB (2011 - 2014)

Company Filing History:


Years Active: 2002-2014

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Purine Derivatives
Pyrimidine Compounds
Protein Kinase Inhibitors
Antiproliferative Compounds
Carrier Based Drug Delivery
Cyclin Dependent Kinase Inhibitors
Anti-Cancer Compounds
Transport Vectors
20 patents (USPTO):Explore Patents

Title: Peter Martin Fischer - Innovative Inventor from Angus, GB

Introduction: Peter Martin Fischer is a renowned inventor hailing from Angus, GB, known for his groundbreaking contributions to various industries.

Latest Patents: Peter Martin Fischer holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Peter Martin Fischer has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Peter Martin Fischer has collaborated with top inventors, patent attorneys, and companies worldwide, fostering a culture of innovation and excellence in all his projects.

Conclusion: Peter Martin Fischer's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…